Ionis Pharmaceuticals, Inc. (IONS) vs Vaxcyte, Inc. (PCVX)
Ionis Pharmaceuticals, Inc. and Vaxcyte, Inc. are both Biotechnology companies. Vaxcyte, Inc. is the larger, with a market value of $8.5B against $7.4B — 1.1× the size. Vaxcyte, Inc. has the higher net margin (0.00% vs −64.7%) and the lower return on invested capital (−57.3% vs 0.00%). Across the 14 metrics below, Ionis Pharmaceuticals, Inc. leads on 7 and Vaxcyte, Inc. on 7.
Valuation
Profitability
| Metric | IONS | PCVX | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.17% | 0.00% | 65.16% |
| Operating margin | (68.00%) | 0.00% | 0.00% |
| Net margin | (64.66%) | 0.00% | 0.00% |
| Free cash flow margin | (64.93%) | 0.00% | 0.00% |
| Return on equity | (105.50%) | (36.51%) | (57.72%) |
| Return on assets | (18.90%) | (33.03%) | (49.22%) |
| Return on invested capital | 0.00% | (57.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack